Impax Asset Management Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6M | Sell |
|
|||||
|
2025
Q1 | $29.5M | Hold |
|
|||||
|
2024
Q4 | $30M | Hold |
|
|||||
|
2024
Q3 | $28M | Hold |
|
|||||
|
2024
Q2 | $23.6M | Buy |
|
|||||
|
2024
Q1 | $18.7M | Buy |
|
|||||
|
2023
Q4 | $14.7M | Buy |
|
|||||
|
2023
Q3 | $11M | Buy |
|
|||||
|
2023
Q2 | $11.5M | Sell |
|
|||||
|
2023
Q1 | $14.3M | Sell |
|
|||||
|
2022
Q4 | $15.7M | Sell |
|
|||||
|
2022
Q3 | $20.2M | Buy |
|
|||||
|
2022
Q2 | $16.4M | Buy |
|
|||||
|
2022
Q1 | $18.5M | Buy |
|
|||||
|
2021
Q4 | $20.8M | Buy |
|
|||||
|
2021
Q3 | $13.8M | Buy |
|
|||||
|
2021
Q2 | $10.4M | Sell |
|
|||||
|
2021
Q1 | $12.9M | Sell |
|
|||||
|
2020
Q4 | $12.5M | Hold |
|
|||||
|
2020
Q3 | $12M | Buy |
|
|||||
|
2020
Q2 | $13.1M | Hold |
|
|||||
|
2020
Q1 | $8.5M | Buy |
|
|||||
|
2019
Q4 | $8.01M | Buy |
|
|||||
|
2019
Q3 | $7.2M | Hold |
|
|||||
|
2019
Q2 | $8.25M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Hold |
|
|||||
|
2018
Q4 | $11M | Buy |
|
|||||
|
2018
Q3 | $8.5M | Buy |
|